BGI Genomics

BGI Genomics stands as a global leader in the biotechnology sector, providing cutting-edge genetic tests and sequencing services to a diverse clientele. Since its inception in 1999, BGI Genomics has been at the forefront of genomic research and development, contributing significantly to advancements in areas such as cancer research, bio-sustainability, and personalized medicine.

Operating a vast network of service laboratories across China, Hong Kong, the US, and Europe, BGI Genomics delivers integrated genomic and proteomic services and solutions to academic institutions, pharmaceutical companies, healthcare providers, and various other organizations. These services span a wide array of applications, including basic and translational research, drug discovery, agriculture, and healthcare. With state-of-the-art facilities, including locations at One Broadway, 3rd floor, Cambridge, Massachusetts 02142, US, and Ole Maaløes Vej 3, Copenhagen, Capital Region 2200, DK, BGI Genomics ensures the highest quality and precision in every project.

BGI Genomics is dedicated to pushing the boundaries of genomic science and providing unparalleled services to its global partners. The company continues to innovate with its DNBseq™ sequencing technology, offering scientists worldwide access to high-quality data at competitive costs. We invite the management team at BGI Genomics to enhance your company's presence by creating a customized and exclusive company showcase and product listing on our platform.